What is HU (Hounsfield Units) and How is it Used to Assess Adrenal Incidentalomas?
HU (Hounsfield Units) is a standardized CT density measurement scale where water = 0 HU and air = -1000 HU, and it serves as the critical first-line imaging parameter to distinguish benign adrenal adenomas from potentially malignant lesions on non-contrast CT.
Definition and Measurement
Hounsfield Units quantify tissue density on CT imaging. For adrenal masses, HU values are measured on non-contrast CT by placing regions of interest within the lesion 1, 2. This measurement is highly reliable—even when performed by non-radiologists, with an intraclass correlation coefficient of 0.938 between observers 3.
Critical HU Thresholds for Clinical Decision-Making
≤10 HU: Benign (No Further Imaging Required)
- Lesions measuring ≤10 HU on non-contrast CT are definitively benign lipid-rich adenomas 1, 2
- These patients require no further imaging follow-up if the mass is <4 cm and non-functional 1
- Malignancy risk is 0% at this threshold 4
- You can safely exclude pheochromocytoma screening in these patients if they lack adrenergic symptoms 1
Important caveat: The ≤10 HU threshold has only 47.6% sensitivity for adenomas, meaning it misses 10-40% of benign adenomas that are lipid-poor 5. However, its 93.3% specificity makes it excellent for ruling in benignity when positive.
11-20 HU: Indeterminate Gray Zone (Requires Additional Workup)
- This range represents the indeterminate zone requiring comprehensive evaluation 1, 2
- Malignancy risk is approximately 0.5-11.4% 6, 4
- For lesions <4 cm in this range: Obtain immediate second-line imaging with either washout CT or chemical-shift MRI 1, 2
- Alternative approach: Follow-up imaging at 12 months if immediate additional imaging is not performed 2
- Recent surgical data shows 88.6% of resected lesions in this range were benign, but 11.4% included pheochromocytomas, metastases, and adrenocortical carcinoma 6
>20 HU: Suspicious (High Risk of Malignancy)
- Lesions >20 HU carry a 6.3-33.8% malignancy risk 6, 4
- These require multidisciplinary discussion with consideration for surgical resection 1, 2
- All malignant tumors (adrenocortical carcinoma, metastases, malignant lymphoma) and pheochromocytomas measured ≥10 HU in validation studies 3
- If not resected, follow-up imaging at 6-12 months is mandatory 2
Algorithmic Approach to HU-Based Management
Step 1: Obtain non-contrast CT for any adrenal incidentaloma >1 cm 2
Step 2: Measure HU and apply thresholds:
- ≤10 HU + <4 cm + non-functional → No further imaging 1
- ≤10 HU + ≥4 cm → Repeat imaging at 6-12 months 1
- 11-20 HU → Immediate washout CT or chemical-shift MRI 1, 2
- >20 HU or heterogeneous → Multidisciplinary review, consider surgery 2
Step 3: Regardless of HU value, perform hormonal screening:
- 1 mg dexamethasone suppression test for all patients 1
- Aldosterone-to-renin ratio if hypertensive or hypokalemic 1
- Plasma/urinary metanephrines if >10 HU or symptoms of catecholamine excess 1
Important Limitations and Pitfalls
Washout CT Performance Issues
Critical warning: Approximately 1/3 of pheochromocytomas may show adenoma-like washout patterns, and conversely, 1/3 of adenomas fail to wash out appropriately 1. Malignant masses including adrenocortical carcinoma can also demonstrate adenoma-range washout. Clinicians must be aware these false positives and negatives exist when interpreting washout studies 1.
Alternative Thresholds
Some evidence suggests raising the initial threshold to ≤16 HU (sensitivity 65.4%, specificity 93.3%) followed by absolute percent washout >60% for lesions exceeding 16 HU can improve overall diagnostic accuracy to 93.4% sensitivity and 96.6% positive predictive value 5. However, current guidelines maintain the ≤10 HU standard 1, 2.
Size-Related Considerations
Lesions ≥4 cm require follow-up imaging even if ≤10 HU due to increased malignancy risk with size 1. Growth >5 mm/year warrants repeat functional workup and consideration for adrenalectomy 1.
Functional Correlations
Cortisol-producing adenomas have significantly higher HU values than aldosterone-producing adenomas, independent of mass size 3. This reflects differences in lipid content between these functional tumor types.